XXII News and Press, 22nd Century Group Inc From 11/29/23

2023-11-29 07:36:04 ET More on 22nd Century 22nd Century to sell its hemp/cannabis franchise, stock jumps ~13% after hours 22nd Century Group prices public offering to raise $5.25M Seeking Alpha’s Quant Rating on 22nd Century Historical earnings data f...

BUFFALO, N.Y., Nov. 29, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (“22nd Century” or the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the appointment of&...

2023-11-27 17:00:23 ET 22nd Century Group ( NASDAQ: XXII ) on Monday said it would sell all of its GVB Biopharma hemp/cannabis operations, about a year and a half after acquiring the business. XXII stock surged 12.8% to $0.24 after hours. XXII will sell the operations to...

BUFFALO, N.Y., Nov. 27, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ) (the “Company” or “22nd Century”), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has ...

BUFFALO, N.Y., Nov. 08, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced that it has aga...

BUFFALO, N.Y., Nov. 07, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis, and hops, today announced the signi...

22nd Century Group Inc (XXII) is expected to report $-0.91 for Q3 2023

2023-11-06 07:39:37 ET More on 22nd Century 22nd Century Group, Inc. (XXII) Q2 2023 Earnings Call Transcript 22nd Century Group prices public offering to raise $5.25M 22nd Century announces proposed public offering Seeking Alpha’s Quant Rating on 22nd ...

BUFFALO, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, announced that it supports the ...

2023-10-25 09:25:27 ET More on 22nd Century 22nd Century Group, Inc. (XXII) Q2 2023 Earnings Call Transcript 22nd Century Group prices public offering to raise $5.25M 22nd Century announces proposed public offering For further details see: 22nd Century Gr...